Cannabinoid Drugs-Related Neuroprotection as a Potential Therapeutic Tool Against Chemotherapy-Induced Cognitive Impairment
In recent years, and particularly associated with the increase of cancer patients’ life expectancy, the occurrence of cancer treatment sequelae, including cognitive impairments, has received considerable attention. Chemotherapy-induced cognitive impairments (CICI) can be observed not only during pha...
Guardado en:
Autores principales: | Laura Boullon, Raquel Abalo, Álvaro Llorente-Berzal |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9e632277a1814193ae0063e55640b31c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses
por: Kenneth B. Walsh, et al.
Publicado: (2021) -
Sistema endocanabinoide y desarrollo de esteatosis hepática
por: Valenzuela,Carina, et al.
Publicado: (2014) -
Cannabinoid Therapeutics in Chronic Neuropathic Pain: From Animal Research to Human Treatment
por: Raquel Maria P. Campos, et al.
Publicado: (2021) -
Endogenous cannabinoids may regulate chronic inflammation in aspirin-exacerbated respiratory disease
por: Joshua M. Levy
Publicado: (2020) -
The strengths and limits of cannabinoids and their receptors in cancer: Insights into the role of tumorigenesis-underlying mechanisms and therapeutic aspects
por: Fatemeh Hosami, et al.
Publicado: (2021)